Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Haihong Henglong Medical Technology is a specialized healthcare information technology company based in China, primarily focused on medical insurance fund supervision and pharmacy benefit management (PBM). As a subsidiary of Guoxin Health Information Technology, the company leverages big data and AI to provide intelligent auditing services for medical insurance payments, helping to prevent fraud and optimize healthcare expenditures. Its services are widely utilized by government social security departments and commercial insurance companies to manage drug costs and improve hospital billing accuracy. The company plays a significant role in the digitalization of China's healthcare reimbursement landscape. It was instrumental in introducing the PBM model to the Chinese market, adapting international standards to local regulatory requirements. Haihong Henglong's platform is integrated into numerous provincial and municipal social security systems, supporting the efficient allocation of healthcare resources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haihong Henglong.